Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines

Manisha H. Shah; Whitney S. Goldner; Thorvardur R. Halfdanarson; Emily Bergsland; Jordan D. Berlin; Daniel Halperin; Jennifer Chan; Matthew H. Kulke; Al B. Benson; Lawrence S. Blaszkowsky; Jennifer Eads; Paul F. Engstrom; Paul Fanta; Thomas Giordano; Jin He; Martin J. Heslin; Gregory P. Kalemkerian; Fouad Kandeel; Sajid A. Khan; Wajih Zaheer Kidwai; Pamela L. Kunz; Boris W. Kuvshinoff; Christopher Lieu; Venu G. Pillarisetty; Leonard Saltz; Julie Ann Sosa; Jonathan R. Strosberg; Craig A. Sussman; Nikolaos A. Trikalinos; Nataliya A. Uboha; Jonathan Whisenant; Terence Wong; James C. Yao; Jennifer L. Burns; Ndiya Ogba; Griselda Zuccarino-Catania

doi:10.6004/jnccn.2018.0056

Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines

Manisha H. Shah, Whitney S. Goldner, Thorvardur R. Halfdanarson, Emily Bergsland, Jordan D. Berlin, Daniel Halperin, Jennifer Chan, Matthew H. Kulke, Al B. Benson, Lawrence S. Blaszkowsky, Jennifer Eads, Paul F. Engstrom, Paul Fanta, Thomas Giordano, Jin He, Martin J. Heslin, Gregory P. Kalemkerian, Fouad Kandeel, Sajid A. Khan, Wajih Zaheer KidwaiPamela L. Kunz, Boris W. Kuvshinoff, Christopher Lieu, Venu G. Pillarisetty, Leonard Saltz, Julie Ann Sosa, Jonathan R. Strosberg, Craig A. Sussman, Nikolaos A. Trikalinos, Nataliya A. Uboha, Jonathan Whisenant, Terence Wong, James C. Yao, Jennifer L. Burns, Ndiya Ogba, Griselda Zuccarino-Catania

Research output: Contribution to journal › Review article › peer-review

296 Scopus citations

Abstract

The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

Original language	English
Pages (from-to)	693-702
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	16
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2018.0056
State	Published - Jun 1 2018

Access to Document

10.6004/jnccn.2018.0056

Cite this

Shah, M. H., Goldner, W. S., Halfdanarson, T. R., Bergsland, E., Berlin, J. D., Halperin, D., Chan, J., Kulke, M. H., Benson, A. B., Blaszkowsky, L. S., Eads, J., Engstrom, P. F., Fanta, P., Giordano, T., He, J., Heslin, M. J., Kalemkerian, G. P., Kandeel, F., Khan, S. A., ... Zuccarino-Catania, G. (2018). Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 16(6), 693-702. https://doi.org/10.6004/jnccn.2018.0056

@article{bd8255658df94c7496d08da80133378b,

title = "Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines",

abstract = "The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.",

author = "Shah, {Manisha H.} and Goldner, {Whitney S.} and Halfdanarson, {Thorvardur R.} and Emily Bergsland and Berlin, {Jordan D.} and Daniel Halperin and Jennifer Chan and Kulke, {Matthew H.} and Benson, {Al B.} and Blaszkowsky, {Lawrence S.} and Jennifer Eads and Engstrom, {Paul F.} and Paul Fanta and Thomas Giordano and Jin He and Heslin, {Martin J.} and Kalemkerian, {Gregory P.} and Fouad Kandeel and Khan, {Sajid A.} and Kidwai, {Wajih Zaheer} and Kunz, {Pamela L.} and Kuvshinoff, {Boris W.} and Christopher Lieu and Pillarisetty, {Venu G.} and Leonard Saltz and Sosa, {Julie Ann} and Strosberg, {Jonathan R.} and Sussman, {Craig A.} and Trikalinos, {Nikolaos A.} and Uboha, {Nataliya A.} and Jonathan Whisenant and Terence Wong and Yao, {James C.} and Burns, {Jennifer L.} and Ndiya Ogba and Griselda Zuccarino-Catania",

note = "Funding Information: This activity is supported by educational grants from AstraZeneca, Celldex Therapeutics, Celgene Corporation, Genentech, Jazz Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, and Seattle Genetics, Inc. This activity is supported by independent educational grants from AbbVie, Merck & Co., Inc. and NOVOCURE. Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2018",

month = jun,

day = "1",

doi = "10.6004/jnccn.2018.0056",

language = "English",

volume = "16",

pages = "693--702",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "6",

}

Shah, MH, Goldner, WS, Halfdanarson, TR, Bergsland, E, Berlin, JD, Halperin, D, Chan, J, Kulke, MH, Benson, AB, Blaszkowsky, LS, Eads, J, Engstrom, PF, Fanta, P, Giordano, T, He, J, Heslin, MJ, Kalemkerian, GP, Kandeel, F, Khan, SA, Kidwai, WZ, Kunz, PL, Kuvshinoff, BW, Lieu, C, Pillarisetty, VG, Saltz, L, Sosa, JA, Strosberg, JR, Sussman, CA, Trikalinos, NA, Uboha, NA, Whisenant, J, Wong, T, Yao, JC, Burns, JL, Ogba, N & Zuccarino-Catania, G 2018, 'Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 6, pp. 693-702. https://doi.org/10.6004/jnccn.2018.0056

TY - JOUR

T1 - Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines

AU - Shah, Manisha H.

AU - Goldner, Whitney S.

AU - Halfdanarson, Thorvardur R.

AU - Bergsland, Emily

AU - Berlin, Jordan D.

AU - Halperin, Daniel

AU - Chan, Jennifer

AU - Kulke, Matthew H.

AU - Benson, Al B.

AU - Blaszkowsky, Lawrence S.

AU - Eads, Jennifer

AU - Engstrom, Paul F.

AU - Fanta, Paul

AU - Giordano, Thomas

AU - He, Jin

AU - Heslin, Martin J.

AU - Kalemkerian, Gregory P.

AU - Kandeel, Fouad

AU - Khan, Sajid A.

AU - Kidwai, Wajih Zaheer

AU - Kunz, Pamela L.

AU - Kuvshinoff, Boris W.

AU - Lieu, Christopher

AU - Pillarisetty, Venu G.

AU - Saltz, Leonard

AU - Sosa, Julie Ann

AU - Strosberg, Jonathan R.

AU - Sussman, Craig A.

AU - Trikalinos, Nikolaos A.

AU - Uboha, Nataliya A.

AU - Whisenant, Jonathan

AU - Wong, Terence

AU - Yao, James C.

AU - Burns, Jennifer L.

AU - Ogba, Ndiya

AU - Zuccarino-Catania, Griselda

N1 - Funding Information: This activity is supported by educational grants from AstraZeneca, Celldex Therapeutics, Celgene Corporation, Genentech, Jazz Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, and Seattle Genetics, Inc. This activity is supported by independent educational grants from AbbVie, Merck & Co., Inc. and NOVOCURE. Publisher Copyright: © JNCCN-Journal of the National Comprehensive Cancer Network.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

AB - The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

UR - http://www.scopus.com/inward/record.url?scp=85049060933&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0056

DO - 10.6004/jnccn.2018.0056

M3 - Review article

C2 - 29891520

AN - SCOPUS:85049060933

SN - 1540-1405

VL - 16

SP - 693

EP - 702

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this